[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health":3,"$f1hh4qx3igqkki":14},{"ok":4,"db":5,"lastOrangeBookRun":6,"lastDrugsFdaRun":9,"lastAlertsRun":12,"stale":13},true,"ok",{"status":5,"startedAt":7,"finishedAt":8,"lastOkAt":8},"2026-10-26T06:44:32.239Z","2026-10-26T06:44:53.640Z",{"status":5,"startedAt":10,"finishedAt":11,"lastOkAt":11},"2026-10-26T06:45:02.648Z","2026-10-26T06:45:13.189Z",null,false,{"tradeName":15,"ingredient":16,"applicant":17,"applicantSlug":18,"applNos":19,"loe":12,"latestLoe":12,"basis":21,"carveOutPossible":13,"openStrengths":22,"headlineStrengths":22,"headlineFallback":4,"approvalsBeforeLoe":23,"products":24,"patents":42,"exclusivities":43,"paragraphIv":44,"catalysts":46},"BLOXIVERZ","NEOSTIGMINE METHYLSULFATE","EXELA PHARMA","exela-pharma",[20],"204078","none",3,0,[25,33,37],{"key":26,"applNo":20,"productNo":27,"dosageForm":28,"route":29,"strength":30,"approvalDate":31,"rld":4,"teCode":12,"type":32,"loe":12,"basis":21,"carveOutPossible":13},"204078-001","001","SOLUTION","INTRAVENOUS","5MG\u002F10ML (0.5MG\u002FML)","2013-05-31","DISCN",{"key":34,"applNo":20,"productNo":35,"dosageForm":28,"route":29,"strength":36,"approvalDate":31,"rld":4,"teCode":12,"type":32,"loe":12,"basis":21,"carveOutPossible":13},"204078-002","002","10MG\u002F10ML (1MG\u002FML)",{"key":38,"applNo":20,"productNo":39,"dosageForm":28,"route":29,"strength":40,"approvalDate":41,"rld":4,"teCode":12,"type":32,"loe":12,"basis":21,"carveOutPossible":13},"204078-003","003","5MG\u002F5ML (1MG\u002FML)","2023-10-27",[],[],{"asOf":12,"firstFiled":12,"entries":45},[],[]]